14.1 C
London
Saturday, October 19, 2024
Subscribe
HomeTagsEisai

Tag: Eisai

spot_imgspot_img
Business

Japan – Eisai Presents New Findings for Antibody Drug Conjugate Farletuzumab Ecteribulin at 2022 ASCO Annual Meeting

Eisai Co., Ltd. announced today new investigational data from the platinum-resistant ovarian cancer (PROC) cohort expansion of a Phase 1 study (Study 101)...
Business

Japan – Eisai Contributes to the Science of Cancer Medicine at ASCO 2022

Eisai Co., Ltd. announced today the presentation of research across various types of cancer from its oncology portfolio during the 2022 American Society...
Business

Japan – Eisai: MHLW Grants Orphan Drug Designation in Japan to Mecobalamin Ultrahigh-Dose Formulation with Prospective Indication for Delaying the Progression of Disease and...

Eisai Co., Ltd. announced today that it has received orphan drug designation for ultrahigh-dose mecobalamin, with a prospective indication for delaying the progression...
Business

Eisai Completes Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab for Early Alzheimer’s Disease Under the Accelerated Approval Pathway

Eisai Co., Ltd. and Biogen Inc. announced today that Eisai has completed the rolling submission to the U.S. Food and Drug Administration (FDA) of...
Business

Eisai Initiates Preparation for New Drug Application, Based on the Results of an Investigator-Initiated Clinical Trial of Ultrahigh-Dose Mecobalamin for Amyotrophic Lateral Sclerosis in...

Eisai Co., Ltd. today announced that it has initiated preparation on a New Drug Application for ultrahigh-dose mecobalamin (development code: E0302) for amyotrophic lateral...
Business

Japan – Eisai: Economic Arrangements of Amendment to Alzheimer’s Disease Treatment Collaboration Agreement with Biogen

Eisai Co., Ltd. announced the following economic arrangements agreed in the amendment to Alzheimer's disease collaboration agreement with Biogen Inc. separately announced today....
Business

Japan – Biogen and Eisai Amend Collaboration Agreements on Alzheimer’s Disease Treatments

Biogen Inc. (Nasdaq: BIIB) and Eisai Co., Ltd. announced today that the companies have amended their existing collaboration agreement on aducanumab, which is...
1...8910...15Page 9 of 15

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img

Company

Each template in our ever growing studio library can be added and moved around within any page effortlessly with one click.

Latest

The 15th Turkish-Arab Economic Forum (TAFF 2024) took place at the Four Seasons Bosphorus Hotel in Istanbul

Business 0
ISTANBUL, October 18, 2024 - (ACN Newswire) - The...

China Medical System: First Ruxolitinib Cream’s Prescriptions for Vitiligo Issued in the Greater Bay Area

Business 0
SHENZHEN, CHINA, Oct 18, 2024 - (ACN Newswire) - China...

Leaders Corporate Announces Strategic Partnership with Shomi to Implement Odoo ERP

Business 0
By integrating Odoo ERP, Leaders Corporate will consolidate essential...

Popular

The 15th Turkish-Arab Economic Forum (TAFF 2024) took place at the Four Seasons Bosphorus Hotel in Istanbul

Business 0
ISTANBUL, October 18, 2024 - (ACN Newswire) - The...

China Medical System: First Ruxolitinib Cream’s Prescriptions for Vitiligo Issued in the Greater Bay Area

Business 0
SHENZHEN, CHINA, Oct 18, 2024 - (ACN Newswire) - China...

Leaders Corporate Announces Strategic Partnership with Shomi to Implement Odoo ERP

Business 0
By integrating Odoo ERP, Leaders Corporate will consolidate essential...

Sitemap

© 2004-2024 Webnewswire, All Rights Reserved